Evidence map›Paper›PMID 40778121›Full record

ArticlemedRxiv : the preprint server for health sciences2025

Genetic risk effects on psychiatric disorders act in sets.

Jolien Rietkerk, Morten Dybdahl Krebs, Joel Mefford, Lianyun Huang, Kajsa-Lotta Georgii Hellberg, iPSYCH Study Consortium, Anders Børglum, Thomas Werge, Kenneth S Kendler, Jonathan Flint and 3 more

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Jolien RietkerkHelmholtz Pioneer Campus, Helmholtz Zentrum München, Neuherberg, Germany.ORCID 0000-0002-7539-787X
Morten Dybdahl KrebsInstitute of Biological Psychiatry, Mental Health Center - Sct Hans, Copenhagen University Hospital - Mental Health Services CPH, Copenhagen, Denmark.ORCID 0000-0002-4452-0732
Joel MeffordInstitute of Biological Psychiatry, Mental Health Center - Sct Hans, Copenhagen University Hospital - Mental Health Services CPH, Copenhagen, Denmark.ORCID 0000-0003-3036-545X
Lianyun HuangHelmholtz Pioneer Campus, Helmholtz Zentrum München, Neuherberg, Germany.ORCID 0000-0003-2456-4233
Kajsa-Lotta Georgii HellbergInstitute of Biological Psychiatry, Mental Health Center - Sct Hans, Copenhagen University Hospital - Mental Health Services CPH, Copenhagen, Denmark.ORCID 0000-0003-4779-7494
iPSYCH Study Consortium
Anders BørglumDepartment of Biomedicine, Aarhus University, Aarhus, Denmark.ORCID 0000-0001-8627-7219
Thomas WergeInstitute of Biological Psychiatry, Mental Health Center - Sct Hans, Copenhagen University Hospital - Mental Health Services CPH, Copenhagen, Denmark.ORCID 0000-0003-1829-0766
Kenneth S KendlerVirginia Institute for Psychiatric and Behavioral Genetics and Department of Psychiatry, Virginia Commonwealth University, Richmond, VA, USA.ORCID 0000-0001-8689-6570
Jonathan FlintDepartment of Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.ORCID 0000-0002-9427-4429
Andrew J SchorkInstitute of Biological Psychiatry, Mental Health Center - Sct Hans, Copenhagen University Hospital - Mental Health Services CPH, Copenhagen, Denmark.ORCID 0000-0003-4164-9335
Andrew DahlSection of Genetic Medicine, University of Chicago, Chicago, IL, USA.ORCID 0000-0001-6520-4766
Na CaiHelmholtz Pioneer Campus, Helmholtz Zentrum München, Neuherberg, Germany.ORCID 0000-0001-7496-2075

Funding

2/7 Psychiatric Genomics Consortium: Advancing Discovery and ImpactR01MH124851 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI BOERGLUM, ANDERS, DAVIS, LEA K · 2021 to 2025
$5.4M
Improving the interpretability of genetic studies of major depressive disorder to identify risk genesR01MH130581 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI JONATHAN FLINT, KENNETH SEEDMAN KENDLER · 2022 to 2026
$2.8M
NIMH NIH HHS R01 MH124851NIMH NIH HHS R01 MH130581
6 · The paper itself

Abstract

Genetic studies of psychiatric disorders have typically assumed that all genetic effects contribute additively to disease liability. However, it is likely that psychiatric disorders have unrecognized subtypes, where synergistic sets of risk variants co-occur within certain cases more than expected under additivity. The existence of synergistic sets induces a structured form of statistical interactions called coordinated epistasis. We test for these interactions in five psychiatric disorders and find evidence for synergistic sets, and by extension, disorder subtypes. We further find that synergistic sets contributing to comorbidities are mostly disorder-specific, despite high genetic correlations between disorders, supporting current diagnostic distinctions between disorders. Finally, we find that genetic risk factors shared across disorders identify a cross-disorder subtype that is likely the result of heritable confounders, rather than disorder-specific etiology. Our results show that genetic risk effects for psychiatric disorders act in sets, implying the existence of subtypes, and re-interpret the importance of shared genetic effects in understanding disease biology and classification.

Identifiers

PMID40778121
PMCPMC12330452

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.